NR 449 Week 6 RUA Group Project_Enhanced Recovery After Surgery (ERAS) Protocol

Student Roles Megan Russell Mariette Salloum Sienneh Moifolley Contribution: Contribution: Orthopedic/ Contribution: Survival/ Problem ID & LOS Gyn Data & Validity Process Optimization Data Data Synthesis • Li et al. (2022) • Chen et al. (2025) • Madan et al. • Yeniay et al. (2023) • J in et al. (2025) (2023) • Lu et al. (2020) Jessica Nwachukwu Erica Willis All members contributed Contribution: Protocol Contribution: Readmissio equally to slide creation, Compliance & Safety n Data & Conclusion editing, and final review. • Grilo et al. (2024) • Kim et al. (2021) • • Ripollés-Melchor et Zhang et al. (2022) al. (2020) Description of Group’s Research Process • PICO(T) Formulation – Defined population, intervention, comparison, outcomes, and timeframe • Systematic Search – Focused on recent primary research (RCTs) • Evidence Appraisal – Assessed validity, level of evidence, and clinical significance • Prioritized Level II Evidence – Ensured strongest internal validity What is Still Needed? Implementation Science •Address nurse skepticism and physician habits Fiscal Analysis • Link high protocol adherence to cost reduction Long-Term Outcomes • Study patient education impact on 90-day readmission Summary of Validity of Qualitative and Quantitative Evidence Quantitative Evidence (9/10) • Highest Level: RCTs provided the strongest evidence, directly supporting the PICOT question. • Source: Majority (9/10) of studies were quantitative. Qualitative Evidence (1/10) • Context: One QOL study provided valuable patient context and satisfaction data. • Conclusion: Confirmed rapid recovery and no negative impact on patient comfort. Practice Change Recommendations With Measurable Outcomes and Feasibility Issues Identified Recommendation • Mandate ERAS Protocol as Standard of Care • For all eligible adult surgical patients to standardize care and improve outcomes. Measurable Outcomes & Feasibility • Measurable Outcome: Reduce Average LOS by 20% within 6 months. • Measurable Outcome: Reduce PONV incidence by 50% in the ERAS patient group. • Feasibility: High. Relies on training and policy implementation, not costly equipment purchases. Conclusion Addressing the Clinical Problem • Purpose: To identify a solution to prolonged surgical recovery and high morbidity using evidence. • Did We Achieve It: Yes, the project successfully synthesized Level II evidence to recommend ERAS. • PICOT Answered: ERAS leads to shorter hospital stays and fewer complications after surgery compared to traditional care. • Data in Practice: Absolutely. The homogenous, Level II data can be used immediately to justify a policy mandate for superior patient care. • How Did It End: The research phase concludes with a strong, definitive recommendation for clinical practice change.